First-Line PD-1 Inhibitor-Based Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Revised Systematic Review and Meta-Analysis of Phase III Trials.
- DOI
- 10.1002/cnr2.70660
- Published
- 2026 Sep
- Container
- Cancer reports (Hoboken, N.J.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cnr2.70660,
title = {First-Line PD-1 Inhibitor-Based Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Revised Systematic Review and Meta-Analysis of Phase III Trials.},
author = {Rothweiler V and Roderburg C and Koeksal M and Jensen BEO and Feldt T and Gencer I and Fischer JC and Budach W and Knoefel WT and Lu G and Bölke E},
year = {2026},
journal = {Cancer reports (Hoboken, N.J.)},
doi = {10.1002/cnr2.70660},
url = {https://doi.org/10.1002/cnr2.70660}
}RIS
TY - JOUR TI - First-Line PD-1 Inhibitor-Based Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Revised Systematic Review and Meta-Analysis of Phase III Trials. AU - Rothweiler V AU - Roderburg C AU - Koeksal M AU - Jensen BEO AU - Feldt T AU - Gencer I AU - Fischer JC AU - Budach W AU - Knoefel WT AU - Lu G AU - Bölke E PY - 2026 JO - Cancer reports (Hoboken, N.J.) DO - 10.1002/cnr2.70660 UR - https://doi.org/10.1002/cnr2.70660 ER -
APA
V, R., C, R., M, K., BEO, J., T, F., I, G., JC, F., W, B., WT, K., G, L., & E, B. (2026). First-Line PD-1 Inhibitor-Based Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Revised Systematic Review and Meta-Analysis of Phase III Trials.. Cancer reports (Hoboken, N.J.). https://doi.org/10.1002/cnr2.70660
Source records
- pubmed · retrieved 2026-09-25T18:02:27.452Z